Serina Therapeutics, Inc. (SER) stock
SERNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.35−0.01 (-1.10%)
Close on Nov 18, 2026Market cap $34.29MP/E –Yield –
Serina Therapeutics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Serina Therapeutics's gross profit for the twelve months ending Dec 31, 2023 was $102.00K, up 385.7% year over year. For fiscal 2023 it was $102.00K, up 385.7% from the year before. The highest annual figure on record is $1.48M in fiscal 2019.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $102.00K | +385.7% |
| FY2022 | Dec 31, 2022 | $21.00K | -83.2% |
| FY2021 | Dec 31, 2021 | $125.00K | -62.7% |
| FY2020 | Dec 31, 2020 | $335.00K | -77.4% |
| FY2019 | Dec 31, 2019 | $1.48M | +43.8% |
| FY2018 | Dec 31, 2018 | $1.03M | -16.5% |
| FY2017 | Dec 31, 2017 | $1.24M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $55.00K | +685.7% |
| Q3 FY2023 | Sep 30, 2023 | $34.00K | +750.0% |
| Q2 FY2023 | Jun 30, 2023 | $4.00K | -33.3% |
| Q1 FY2023 | Mar 31, 2023 | $9.00K | +125.0% |
| Q4 FY2022 | Dec 31, 2022 | $7.00K | -73.1% |
| Q3 FY2022 | Sep 30, 2022 | $4.00K | -81.8% |
| Q2 FY2022 | Jun 30, 2022 | $6.00K | -75.0% |
| Q1 FY2022 | Mar 31, 2022 | $4.00K | -92.5% |
| Q4 FY2021 | Dec 31, 2021 | $26.00K | -83.0% |
| Q3 FY2021 | Sep 30, 2021 | $22.00K | -57.7% |
| Q2 FY2021 | Jun 30, 2021 | $24.00K | -42.9% |
| Q1 FY2021 | Mar 31, 2021 | $53.00K | -39.8% |
| Q4 FY2020 | Dec 31, 2020 | $153.00K | -67.4% |
| Q3 FY2020 | Sep 30, 2020 | $52.00K | -85.6% |
| Q2 FY2020 | Jun 30, 2020 | $42.00K | -87.2% |
| Q1 FY2020 | Mar 31, 2020 | $88.00K | -72.9% |
| Q4 FY2019 | Dec 31, 2019 | $470.00K | +253.4% |
| Q3 FY2019 | Sep 30, 2019 | $362.00K | -5.7% |
| Q2 FY2019 | Jun 30, 2019 | $327.00K | -15.1% |
| Q1 FY2019 | Mar 31, 2019 | $325.00K | +150.0% |
| Q4 FY2018 | Dec 31, 2018 | $133.00K | – |
| Q3 FY2018 | Sep 30, 2018 | $384.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $385.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $130.00K | – |
See a number that looks wrong?